Page 93 - AN-3-4

Advanced Neurology SARS-CoV-2 in age-associated neurodegeneration

doi: 10.1038/s41591-022-01689-3 manifestations, neuropathology, neuroimaging,
electrophysiology, and cerebrospinal fluid findings. BMC
22. Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in
long COVID: A cohort study. Lancet Diabetes Endocrinol. Infect Dis. 2021;21(1):515.
2022;10(5):311-321. doi: 10.1186/s12879-021-06185-6
doi: 10.1016/S2213-8587(22)00044-4 33. Mao L, Jin H, Wang M, et al. Neurologic manifestations
23. Hayase Y, Tobita K. Influenza virus and neurological of hospitalized patients with coronavirus disease 2019 in
diseases. Psychiatry Clin Neurosci. 1997;51(4):181-184. Wuhan, China. JAMA Neurol. 2020;77(6):683-690.
doi: 10.1111/j.1440-1819.1997.tb02580.x doi: 10.1001/jamaneurol.2020.1127
24. Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive 34. Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J.
impairment in Post-COVID-19 syndrome: A systematic Cognitive profile following COVID-19 infection: Clinical
review and meta-analysis. Brain Behav Immun. predictors leading to neuropsychological impairment. Brain
2022;101:93-135. Behav Immun Health. 2020;9:100163.
doi: 10.1016/j.bbi.2021.12.020 doi: 10.1016/j.bbih.2020.100163
25. Taquet M, Sillett R, Zhu L, et al. Neurological and 35. Jacot de Alcântara I, Nuber-Champier A, Voruz P, Cionca A,
psychiatric risk trajectories after SARS-CoV-2 infection: Assal F, Péron JA. Cognitive deficits in the acute phase
An analysis of 2-year retrospective cohort studies including of COVID-19: A review and meta-analysis. J Clin Med.
1 284 437 patients. Lancet Psychiatry. 2022;9(10):815-827. 2023;12(3):762.
doi: 10.1016/S2215-0366(22)00260-7 doi: 10.3390/jcm12030762
26. Liu YH, Wu QX, Wang QH, et al. Tracking cognitive 36. Meinhardt J, Radke J, Dittmayer C, et al. Olfactory
trajectories in older survivors of COVID-19 up to 2.5 years transmucosal SARS-CoV-2 invasion as a port of central
post-infection. Nat Aging. 2024;4:1186-1193. nervous system entry in individuals with COVID-19. Nat
Neurosci. 2021;24(2):168-175.
doi: 10.1038/s43587-024-00667-3
doi: 10.1038/s41593-020-00758-5
27. Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR.
Alzheimer’s-like signaling in brains of COVID-19 patients. 37. Siow I, Lee KS, Zhang JJY, Saffari SE, Ng A, Young B. Stroke
Alzheimers Dement. 2022;18(5):955-965. as a neurological complication of COVID-19: A systematic
review and meta-analysis of incidence, outcomes and
doi: 10.1002/alz.12558
predictors: Stroke and COVID-19. J Stroke Cerebrovasc Dis.
28. Yu B, Chen X, Rich S, Mo Q, Yan H. Dynamics of the 2021;30(3):105549.
coronavirus disease 2019 (COVID-19) epidemic in Wuhan
City, Hubei Province and China: A second derivative doi: 10.1016/j.jstrokecerebrovasdis.2020.105549
analysis of the cumulative daily diagnosed cases during the 38. Conway EM, Mackman N, Warren RQ, et al. Understanding
first 85 days. Global Health J. 2021;5(1):4-11. COVID-19-associated coagulopathy. Nat Rev Immunol.
doi: 10.1016/j.glohj.2021.02.001 2022;22(10):639-649.
29. Zuo W, He D, Liang C, et al. The persistence of SARS-CoV-2 doi: 10.1038/s41577-022-00762-9
in tissues and its association with long COVID symptoms: 39. Qureshi AI, Baskett WI, Huang W, et al. Acute ischemic
A cross-sectional cohort study in China. Lancet Infect Dis. stroke and COVID-19: An analysis of 27 676 patients.
2024;24:845-855. Stroke. 2021;52(3):905-912.
doi: 10.1016/S1473-3099(24)00171-3 doi: 10.1161/STROKEAHA.120.031786
30. Buonsenso D, Tantisira KG. Long COVID and SARS-CoV-2 40. Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is
persistence: New answers, more questions. Lancet Infect Dis. associated with changes in brain structure in UK Biobank.
2024;24:796-798. Nature. 2022;604(7907):697-707.
doi: 10.1016/S1473-3099(24)00216-0 doi: 10.1038/s41586-022-04569-5
31. Ding Q, Zhao HJ. Long-term effects of SARS-CoV-2 41. Manca R, De Marco M, Ince PG, Venneri A. Heterogeneity
infection on human brain and memory. Cell Death Discov. in regional damage detected by neuroimaging and
2023;9(1):196. neuropathological studies in older adults with COVID-19:
doi: 10.1038/s41420-023-01512-z A cognitive-neuroscience systematic review to inform the
long-term impact of the virus on neurocognitive trajectories.
32. Guerrero JI, Barragán LA, Martínez JD, et al. Central and
peripheral nervous system involvement by COVID-19: Front Aging Neurosci. 2021;13:646908.
A systematic review of the pathophysiology, clinical doi: 10.3389/fnagi.2021.646908

Volume 3 Issue 4 (2024) 20 doi: 10.36922/an.4267